| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.50B | 20.63B | 17.76B | 15.56B | 14.24B | 8.43B |
| Gross Profit | 1.64B | 1.57B | 1.05B | 1.42B | 2.75B | 1.38B |
| EBITDA | 1.82B | 1.81B | 1.31B | 1.68B | 3.00B | 1.61B |
| Net Income | 797.13M | 747.90M | 353.40M | 655.82M | 1.76B | 781.48M |
Balance Sheet | ||||||
| Total Assets | 28.39B | 28.21B | 26.27B | 26.47B | 23.54B | 18.68B |
| Cash, Cash Equivalents and Short-Term Investments | 1.16B | 243.32M | 1.85B | 327.69M | 760.98M | 342.92M |
| Total Debt | 3.74B | 788.06M | 703.76M | 864.67M | 1.31B | 3.29B |
| Total Liabilities | 17.09B | 17.23B | 16.04B | 16.65B | 14.44B | 11.31B |
| Stockholders Equity | 11.29B | 10.99B | 10.23B | 9.83B | 9.10B | 7.37B |
Cash Flow | ||||||
| Free Cash Flow | -3.73B | 743.06M | -1.12B | 194.22M | 4.99B | -353.17M |
| Operating Cash Flow | -3.40B | 921.15M | -93.55M | 2.91B | 6.19B | 1.35B |
| Investing Cash Flow | 768.68M | -785.18M | 331.03M | -2.13B | -4.13B | -2.65B |
| Financing Cash Flow | 3.23B | -66.95M | -310.73M | -691.23M | -2.25B | 1.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$19.80B | 11.84 | 14.24% | 5.87% | 14.76% | 23.04% | |
75 Outperform | HK$9.89B | 11.51 | 7.26% | ― | -6.79% | 66.07% | |
67 Neutral | HK$2.83B | 10.83 | 8.10% | 4.00% | 3.40% | 151.24% | |
64 Neutral | HK$2.39B | 6.29 | 14.74% | 12.14% | -0.95% | 2.58% | |
63 Neutral | HK$2.00B | 8.40 | 12.21% | 7.98% | 13.52% | 4.95% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | HK$1.75B | 12.52 | 4.73% | 8.06% | -2.44% | -5.98% |